» Articles » PMID: 21240989

Goblet Cell Carcinoids at Extraappendiceal Locations of Gastrointestinal Tract: an Underrecognized Diagnostic Pitfall

Overview
Journal J Surg Oncol
Date 2011 Jan 18
PMID 21240989
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Goblet cell carcinoid (GCC) is a clinicopathologically distinctive tumor that typically arises in appendix and metastasizes frequently. Although rare cases of ostensibly primary extraappendiceal GCC (EGCC) have been reported, the distinction from extraappendiceal metastasis of occult appendiceal primary may be problematic and has not been dealt with systematically in literature.

Methods: We reviewed our combined experience with EGCC at four North American hospitals and reevaluated all EGCC cases published in literature.

Results: We encountered 16 cases that were initially reported as EGCC. Five cases presented with disseminated abdominopelvic spread, nine cases with mass lesions in stomach, ileum, cecum, ascending colon, hepatic flexure, sigmoid, and rectum. One case was found incidentally in an ascending colon adenomatous polyp. A negative appendix was confirmed in 2 (12.5%) cases, whereas a primary appendiceal GCC was discovered in 4 (25%) cases at a later date, and appendix was not available for review in 10 cases (62.5%). Of 10 cases of EGCC found in literature, the tumor sites included stomach, duodenum, jejunum, ileum, cecum, splenic flexure, and rectum. Primary appendiceal tumor was excluded histologically in one (10%), grossly in three (30%), and not at all in six (60%). Nine of our cases were initially misdiagnosed as signet-ring cell adenocarcinomas.

Conclusions: True EGCC is extremely rare. GCC found at locations other than appendix are most likely extraappendiceal presentations of appendiceal primary. A thorough review of the pathologic status of appendix should be a mandatory diagnostic criterion and should always be documented in the pathology reports.

Citing Articles

Case report: Recurrence of primary hepatic neuroendocrine tumors after resection of liver segments IV in 8 years follow-up.

Li C, Bian L, Fan G, Huang Y, Li J, He B Front Med (Lausanne). 2024; 11:1437650.

PMID: 39351005 PMC: 11439660. DOI: 10.3389/fmed.2024.1437650.


The Optimal Approach to Surgical Management of Goblet Cell Carcinoid of the Appendix: A Systematic Review.

Salama M, ONeill M, Ryan E, OSullivan N, Nugent T, Temperley H Diagnostics (Basel). 2024; 14(16).

PMID: 39202258 PMC: 11353492. DOI: 10.3390/diagnostics14161773.


A rare goblet cell adenocarcinoma arising from Barrett's esophagus: the first reported case in the esophagus.

Oh C, Kim S, Oh S J Pathol Transl Med. 2024; 58(2):81-86.

PMID: 38178706 PMC: 10948254. DOI: 10.4132/jptm.2023.12.26.


Appendiceal Goblet Cell Carcinoma: Role of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Gaillard M, Van Eyken P, Verswijvel G, Van der Speeten K Indian J Surg Oncol. 2023; 14(Suppl 1):240-249.

PMID: 37359931 PMC: 10284751. DOI: 10.1007/s13193-023-01748-2.


Goblet cell adenocarcinoma of the ascending colon: An underrecognized diagnostic pitfall.

Limaiem F, Omrani S, Hajri M Clin Case Rep. 2023; 11(1):e6822.

PMID: 36654693 PMC: 9834544. DOI: 10.1002/ccr3.6822.